Clinical Trial Update: A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants [Phase 1]

View source ↗

Summary

This first-in-human Phase 1 study from GlaxoSmithKline is evaluating safety, tolerability, pharmacokinetics and target engagement of GSK4528287 in healthy parti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• GSK4528287

Snippet

Sponsor: GlaxoSmithKline | Conditions: Colitis, Ulcerative | Phase 1 | Status: ACTIVE_NOT_RECRUITING